insights_auto
Why is GMAB down 4.06%?
Dive Deeperchevron_right
GMAB:CPH
Genmab A/S
DKK 2,386.00
arrow_downward
-4.06%(-101.00) 1D
Oct 8, 1:26:01 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKK 2,441.00
High
DKK 2,444.00
Low
DKK 2,360.00
Mkt. cap
148.25B
Avg. vol.
124.01K
Volume
51.14K
52-wk high
DKK 2,603.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
Open
DKK 2,441.00
High
DKK 2,444.00
Low
DKK 2,360.00
Mkt. cap
148.25B
Avg. vol.
124.01K
Volume
51.14K
52-wk high
DKK 2,603.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
TipRanks
·
18 hours ago
Genmab Grants Restricted Stock Units to Board After Extraordinary General Meeting
Stock Titan
·
18 hours ago
Awarded cost-free, Genmab (GMAB)'s 5,300 board stock units vest after three years.
Yahoo Finance
·
19 hours ago
Resolution Adopted at the Extraordinary General Meeting of Genmab A/S Including Grant of Restricted Stock Units to Board Members
Investing.com
·
23 hours ago
H.C. Wainwright raises Genmab stock price target on positive trial data
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com